Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
About this item
Full title
Author / Creator
POLLUX Investigators , Dimopoulos, Meletios A , Oriol, Albert , Nahi, Hareth , San-Miguel, Jesus , Bahlis, Nizar J , Usmani, Saad Z , Rabin, Neil , Orlowski, Robert Z , Komarnicki, Mieczyslaw , Suzuki, Kenshi , Plesner, Torben , Yoon, Sung-Soo , Ben Yehuda, Dina , Richardson, Paul G , Goldschmidt, Hartmut , Reece, Donna , Lisby, Steen , Khokhar, Nushmia Z , O’Rourke, Lisa , Chiu, Christopher , Qin, Xiang , Guckert, Mary , Ahmadi, Tahamtan and Moreau, Philippe
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The addition of daratumumab to lenalidomide and dexamethasone resulted in superior response rate and progression-free survival, as compared with lenalidomide and dexamethasone alone, at a cost of more frequent neutropenia and infusion reactions.
The incorporation of proteasome inhibitors and immunomodulatory drugs into the standard of care has i...
Alternative Titles
Full title
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Authors, Artists and Contributors
Author / Creator
Dimopoulos, Meletios A
Oriol, Albert
Nahi, Hareth
San-Miguel, Jesus
Bahlis, Nizar J
Usmani, Saad Z
Rabin, Neil
Orlowski, Robert Z
Komarnicki, Mieczyslaw
Suzuki, Kenshi
Plesner, Torben
Yoon, Sung-Soo
Ben Yehuda, Dina
Richardson, Paul G
Goldschmidt, Hartmut
Reece, Donna
Lisby, Steen
Khokhar, Nushmia Z
O’Rourke, Lisa
Chiu, Christopher
Qin, Xiang
Guckert, Mary
Ahmadi, Tahamtan
Moreau, Philippe
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_501969
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_501969
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1607751
